RecruitingNCT05437965
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Sponsor
China National Center for Cardiovascular Diseases
Enrollment
1,000 participants
Start Date
Jun 3, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age ≥ 18 years;
- Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
- Patients fully informed about the trial procedures who provide written informed consent.
Exclusion Criteria10
- Patients presenting with any of the following:
- Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy <12 months;
- Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
- Variant angina (Prinzmetal's angina);
- Coronary artery dissection;
- Thrombophilia;
- Stent underexpansion.
- Presence of psychiatric disorders;
- Known inability to complete expected study follow-up for any reason;
- Patients deemed ineligible for enrollment by the investigator.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERTreatment made by experienced clinicians
Treatment made by experienced clinicians
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05437965
Related Trials
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT069547148 locations
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
NCT068211911 location
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
NCT072693661 location
Coronary Artery Disease Assessment Strategies in TAVI Patients
NCT065593321 location
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
NCT058500911 location